As increased activation of mTORC1 is known to mediate PgR expression and we demonstrated that loss of Rictor expression correlated with an ERα− breast cancer phenotype, we next sought to determine if there was a clinical correlation between Rictor or Raptor expression and loss of PgR expression. This evidence concerns the gene RPTOR and breast carcinoma.